Stay updated with breaking news from Pharmaceutical Sciences Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas (GBM), the most deadly form of brain tumors.
This Week in Washington: House Energy and Commerce Committee markup includes 19 healthcare bills; Senate HELP Committee to mark up SUPPORT Act Reauthorization and three other bills;...
A research question posed in Pankaj Desai's lab has led to a decade of research, a clinical trial and major national funding to further investigate a potential new treatment for the most deadly form of brain tumors.
Glioblastoma nearly invariably recurs, generally months after the first brain tumour is surgically removed from the patient. It's as tough as the harshest
In most cases, months after the patient's first tumour is surgically removed, glioblastoma recurs, like the hardest weed